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A B S T R A C T
The recombinant adenoviral gene expression system is a powerful tool for gene delivery. However, it is
difﬁcult to obtain high titers of infectious virus, principally due to the toxicity of the expressed gene
which affects on virus replication in the host HEK293 cells. To avoid these problems, we generated a
Cre-loxP-regulated ﬂuorescent universal vector (termed pAxCALRL). This vector produces recombinant
adenoviruses that express the red ﬂuorescent protein (RFP) instead of the inserted gene during
proliferation, which limits toxicity and can be used to monitor viral replication. Expression of the gene of
interest is induced by co-infection with an adenovirus that expresses Cre-recombinase (AxCANCre).
Recombinant adenovirus produced by this system that express Hnf4a and Foxa2 were used to reprogram
mouse embryo ﬁbroblast (MEF) into induced-hepatocyte-like cells (iHep) following several rounds of
infection, demonstrating the efﬁcacy of this new system.
ã 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Various virus-based vector systems are used for gene transfer,
including adenoviruses, lentiviruses, retroviruses and adeno-
associated viruses. Human adenovirus has a non-segmented linear
double-stranded DNA genome and 57 serotypes, some of which are
pathogenic, such as 3,7, and 21 that induce respiratory disease
[9,13], 8,19 and 37 conjunctivitis [1], 40, 41 and 52 gastroenteritis
[6,8] and the type 14 subfamily severe multi-organ disease [12,21].
In contrast, Adenovirus type 5 (Ad5) is generally considered to be
non-pathogenic and is often used for gene transduction, although a
recent report suggests that it induces obesity [22]. Adenovirus can
infect both actively dividing and terminally differentiated cells [4]
and does not require integration into the host genome for gene
expression [23]. Therefore, recombinant adenovirus is useful for
gene therapy, especially when transient gene expression is
acceptable or beneﬁcial.* Corresponding author.
E-mail address: nakade@brc.riken.jp (K. Nakade).
1 These authors contributed to this work.
http://dx.doi.org/10.1016/j.btre.2016.10.003
2215-017X/ã 2016 The Authors. Published by Elsevier B.V. This is an open access articpAxCAwtit2 is an adenoviral cosmid vector based on Ad5 [5]
which contains the genes required for virus replication but lacks
the E1 gene region. The recombinant adenovirus can only
proliferate in cells such as HEK293 that express the E1A and
E1 B proteins. The E1 gene is replaced by the CAG promoter (fusion
of the cytomegalovirus early enhancer, the chicken beta-actin
promoter and the splice acceptor of rabbit beta globin) [15], the
beta-globin polyadenylation signal and a unique SwaI cloning site,
in order to insert the gene to be expressed. Recombinant
adenovirus can be produced by transfecting HEK293 cells with
this cosmid vector. In general, the percentage of virus producing
cells is quite low even if most of the cells are efﬁciently transfected.
From our experience, only 10 to 100 out of 1 10^6 cells, or
sometimes none of cells produce infectious virus. If virus
producing cells are generated, cell death caused by lytic cycles
of adenovirus can be observed from 14 to 20 days after transfec-
tion. In other words, it takes 2 to 3 weeks to know whether
infectious virus will be obtained.
We generated pAxCALRL, which is a Cre-loxP-regulated
ﬂuorescent universal vector. The vector has a tag-RFP sequence
as a stuffer between two loxP sequences just downstream of a CAG
artiﬁcial promoter. The newly produced SwaI cloning site for the
insertion of genes of interest is situated next to the last loxPle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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the proliferation of the virus can be followed by ﬂuorescence of the
RFP positive colonies, which appear from 5 to 7 days after
transfection.
Adenovirus can infect a broad range of cells and tissue, however,
because of this natural tropism, the use of the virus in vivo is
limited, due to the risk of toxicity from infection of non-targeted
cells [2]. In addition, adenovirus tends to be removed by the
immune system, due to pre-existing antibodies [14]. Better
adenoviruses for in-vivo use are being generated, by modifying
tropism and immuno-susceptibility [3,7,10,11,17,18]. Recently, it
was reported that chemical coupling of adenovirus with a peptide
that has a high afﬁnity for a hepatic stellate cell (HSC) surface
protein drastically facilitates infection of the corresponding cells
[16]. Using this method, Reetz et al. directly reprogrammed hepatic
myoﬁbroblasts into hepatocytes in vivo by introducing an
adenoviral vector that expresses Foxa3, Gata4, Hnf1a, and Hnf4a
[20]. This success demonstrates the usefulness of adenovirus in
vivo, and highlights the need for an easy method to obtain high
titers of virus. Our Cre-loxP regulated ﬂuorescent adenoviral
expression vector can be expected to produce higher viral titers, as
it expresses RFP during viral proliferation instead of the inserted
potentially-toxic gene. It is designed to express the inserted gene
following infection with an adenovirus that expresses Cre
recombinase.
In this article, we described the precise method for generation
of Cre-loxP regulated ﬂuorescent adenoviral vectors that express
Foxa2 and Hnf4a. Thse adenoviral vectors can be also used for
successful direct reprogramming of mouse embryo ﬁbroblasts
(MEF) into hepatocyte-like cells [called induced-Hepatocyte (iHep)
by Sekiya et al.] [19].
2. Materials and methods
2.1. Construction of pRSV-LRL
First of all, we prepared the loxP-RFP-loxP construct based on
the pRC/RSV (Invitrogen)-based expression vector, pRSV-2A
(RDB12341, RIKEN BioResource center). The synthetic oligonu-
cleotides:
loxP-f3 (50-agcttactagtataacttcgtatagcatacattatacgaagttatcg-30)
and
loxP-r3 (50-ctagcgataacttcgtataatgtatgctatacgaagttatactagta-30)
were annealed and cloned into the HindIII and NheI site of
pRSV-2A to generate pRSV-loxP. Then, the fragment of the tag-RFP
open reading frame PCR-ampliﬁed from pTagRFP-N (FP142,
Evrogen) that has SpeI and NheI site on the 50 and 30 ends,
respectively, was inserted into the NheI site of pRSV-loxP to obtain
pRSV-loxP-RFP. The SpeI-NheI fragment of pRSV-loxP-RFP was
cloned into the SpeI site of pRSV-loxP to complete construction of
pRSV-loxP-RFP-loxP(pRSV-LRL).
2.2. Construction of the universal adenovirus vector pAxCALRL
In order to clone the loxP-RFP-loxP(LRL) fragment into the
pAxCAwtit2 cosmid vector for adenovirus production (RDB05213,
RIKEN BioResource Center), the fragment was ampliﬁed by PCR
using pRSV-LRL as a template and a set of primers, Adlx-5
(50-ttggtgtgcacctccaagcttact-30) and Adlx3 (50-aaatctagaccgcggagc-
tagcgataactt-30).
2.2.1. Practically;
Step 1. A mixture of Adlx-5 and Adlx-3 were phosphorylated in
the following conditions; oligomers 200 pmol each, 5 ml of 10
T4 kinase buffer, 5 ml of 10 mM ATP, 20 U of T4 kinase (M0201S,NEB) in a 50 ml reaction. The reaction was incubated at 37 C for
60 min and heat-inactivated at 75 C for 5 min.
Step 2. The loxP-RFP-loxP fragment was ampliﬁed by PCR using
phosphorylated primers in the following conditions; 1 ng of pRSV-
LRL as a template, 2 ml of 10 KOD plus buffer, 0.8 ml of 25 mM
MgSO4, 2 ml of 2 mM dNTPs 0.2 units of KOD plus (KOD-201,
Toyobo) in a 20 ml reaction. The reaction mixture was incubated at
95 C for 10 min followed by 15 thermal cycles [95 C for 10 s, 55 C
for 20 s, 72 C for 40 s]. The PCR product was separated by
electrophoresis, excised and electro-eluted using a dialysis bag.
The DNA fragment was extracted once with phenol/chloroform
and once with chloroform and precipitated with ethanol.
Step 3. 10 mg of pAxCAwtit2 was digested with 40U of SwaI
(R0604, NEB) in a 100 ml reaction containing 1 x NEB#3 buffer and
0.1 mg/ml BSA, followed by dephosphorylation by adding 10 ml of
10CIAP buffer and 20 U of CIAP (M0290, NEB). The reaction was
extracted with phenol/chloroform and precipitated with ethanol.
Step 4. For the ligation reaction, the TA-Blunt Ligation Kit (311-
06543, Nippon gene) was used. A 5 ml reaction solution was
prepared with 50 ng (3.3 fmol) of digested vector from step 3,
0.5 ml of 10 x Enhancer solution, 18 fmol (5 ng) of the insert DNA
(prepared in step 2) and 1 ml of 5 x ligation solution. The molecular
ratio of vector to insert was approximately 1:5. The reaction
solution was incubated at 16 C for 30 min and used for packaging
(Step 5) without further treatment.
Step 5. 5 ml of GigapackIII extract [GigapackIII Plus Packaging
Extract (200206, Agilent Technologies)] was added to the 5 ml of
ligation reaction from Step 4, and incubated for 2 h at room
temperature. The packaged DNA was mixed with 700 ml of E.coli
DH5a grown to a density of 0.6 OD 600 in LB medium supplemented
with 10 mM MgSO4. After incubation for 30 min at 37 C, the bacteria
were plated on LB agar supplemented with 1 mg/ml ampicillin.
Clones containing the LRL construct in the right orientation were
selected by colony-PCR using the speciﬁc primers: pAxCAF1(50-
ggcttctggcgtgtgaccggc-30) and Adlx3 (see above).
2.3. Construction of the pAxCALRL-Foxa2 and pAxCALRL-Hnf4a
adenoviral vectors
The open reading frames of Foxa2 and Hnf4a were ampliﬁed by
PCR as described in steps 1 and 2 (see above) using phosphorylated
primers:
Foxa2-f: (50-atgctgggagccgtgaagatggaagggcacgag-30) and
Foxa2-r (50-ttattaggatgagttcataataggcctg-30) or
Hnf4-f: (50-atgcgactctctaaaacccttgcc-30) and Hnf4-r (50-cta-
gatggcttcttgcttggtgatc-30), respectively.
The PCR products were ligated into the SwaI site of pAxCALRL
following the ligation-packaging protocol (see steps 3 to 5, above)
except that the primers used for the colony PCR screening were
pAxCAF1 and Foxa2-r for Foxa2 and pAxCAF1 and Hnf4-r for
Hnf4a.
2.4. Production of recombinant adenovirus
The adenoviral cosmid vector in E.coli was ampliﬁed in 100 ml
of LB supplemented with 1 mg/ml ampicillin and puriﬁed with the
QIAGEN Plasmid Maxi Kit (12163, Qiagen). The vectors, namely
pAxCALRL-Foxa2 and pAxCALRL-Hnf4, were linearlized with the
Csp45I (BstBI) restriction enzyme (R6571, Promega). HEK293 cells,
cultured in DMEM (11885-084, Thermo Fisher Scientiﬁc) supple-
mented with 10% FCS (10099-141, Thermo Fisher Scientiﬁc) were
transfected with each linearlized cosmid vector using the BBS-
mediated calcium phosphate method. 100 ml of solution contain-
ing 4 mg of digested pAxCALRL-Foxa2 or pAxCALRL-Hnf4a and
250 mM of CaCl2 was prepared and then 100 ml of the 2 BBS
solution [50 mM N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic
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Na2HPO4], was added. After incubation for 20 min at room
temperature, the transfection mixture was added to HEK293 cells.
The pH of the 2 BBS solution, which is very critical for the
efﬁciency of transfection, was carefully adjusted to between
pH6.95 to 6.97 using 1N NaOH. The 2 BBS solution with best
transfection efﬁciency was chosen in pilot transfections. After
overnight incubation, the transfected HEK293 cells were spread on
24 well plates and incubated for a further 10–14 days. Typically,
RFP positive cells appeared on the day following transfection. The
cells began to die from day 7, and were almost all dead after 14 days
of transfection, because of the lytic cycles of adenovirus. The
adenovirus clone, which came from a single RFP positive colony,
was harvested by gathering both medium and cell debris. The virus
particles were released from cell debris using 3 freeze-and-thaw
cycles. The “1 st virus clones” of AxCALRL-Foxa2 and AxCALRL-
Hnf4 adenovirus were stored at 80 C, until further ampliﬁcation.
In order to amplify the adenovirus for experimental purposes,
HEK293 cells in 6 cm were infected with 10 ml of the “1 st virus
clones”. The infected cells were incubated until the cells became
round and almost detached from the surface of the dish. The cells
containing replicated virus were harvested using cell lifter (2008,
Corning) together with medium. The medium and the cell debris
were subjected to 3 cycles of freeze-and-thaw, and the cell debris
was removed by centrifugation. The supernatant was stored at
80 C as the “2nd virus clones”. Finally, the “3rd virus clones”
were prepared by infecting HEK293 cells in 10 cm dish 100ul of 2nd
virus clone.
2.5. Determination of virus concentration
In order to determine the concentration of virus, Adeno-X Rapid
Titer Kit (63225, Clontech) was used following the manufacturer's
instruction. Additionally, Adeno-X GoStix (632270, Clontech) was
used to check the approximate viral concentration within a short
period of time.
2.6. Comparison of proliferation rates of adenovirus with and without
stuffer
HEK293 cells were cultured overnight in the presence of DMEM
supplemented with 0.3% FCS and then infected with AxCALRL-
Hnf4 or AxCA-Hnf4. After culturing, the cells were lysed at several
time points in TE supplemented with 1% SDS and the DNA was
extracted once with phenol and once with chloroform. The relative
amounts of viral and cellular DNA were analysed by real-time PCR
using speciﬁc primers for the adenovirus type 5 hexon
(50-cccgtcaactgagcgcttaatttc-30 and 50-acctttaagaaggtggccattacc-
30) and the mouse 28S ribosomal RNA (50-ggcggccaagcgttcatagc-
30 and 50-gccaagcacatcaccaaat-30) genes, respectively. The amounts
of viral DNA were normalised with 28S gene DNA. The log10 of viral
DNA amounts were plotted against time after infection. The same
experiment was done for their Foxa2 counterparts, AxCALRL-
Foxa2 and AxCA-Foxa2.
2.7. Detection of cre-loxP dependent recombination
MEF was infected with AxCALRL-Foxa2, AxCALRL-Hnf4a and
AxCANCre, (RDB01748, RIKEN Bioresource center) following the
protocol described above. After 2 to 7 days of infection, the cells
were lysed with 1% SDS in TE and the DNA was extracted once with
phenol and once with chloroform. Genomic DNA was analysed by
PCR using AmpliTaq Gold1 360 Master Mix (4398881, Thermo
Fisher) and a set of primers, pAxCAF1 (indicated as “primer 1” in
Fig. 2A) and pAxCALRL-r (50-tctagaccgcggtacctcagctagcg-30,“primer 2” in Fig. 2A), which was designed to amplify both
excised and non-excised viral DNA. The PCR products were
subjected to agarose gel electrophoresis to defect the different
size products. For quantitative analysis, different sets of primers
were used: RFP 5-f (50-ggtgtttactatgtggaccatagac-30, “primer 3” in
Fig. 2A) and pAxCALRL-r for the non-excised viral genome, and
pAxCAF1 and pAxCALRL-r for both the excised and non-excised
viral genomes. The reactions, which containing Power SYBR Green
PCR Master Mix (4368702, Thermo Fisher) and the indicated
primers, were analysed using the StepOnePlusTM Real-Time PCR
System (4376600, Thermo Fisher) with following thermal cycle
condition; pre-incubation 95 C for 10 min then 95 C for 10 s, 60 C
for 30 s and 72 C for 30 s.
2.8. Generation of induced-Hepatocyte (iHep)
Direct reprogramming of mouse embryo ﬁbroblasts (MEF) to
Hepatocyte was performed according the method established
by Sekiya et al. (Sekiya and Suzuki). 2.5 10^4 cells/well of MEF
were plated on 12 well dishes and infected with AxCALRL-
Foxa2 and AxCALRL-Hnf4a at a MOI (multiplicity of infection) of
10. On the next day, the cells were infected with AxCANCre at a
MOI of 20 for Cre-loxP dependent DNA recombination. This
infection process was repeated every 7 days up to day 28, giving
a total of 5 separate infections. MEF were cultured ﬁrst in
DMEM + 10% FCS for two days, followed by Hepato-medium(-/-)
[1:1 mixture of DMEM and F-12 (21331, Life technologies)
supplemented with 10% FCS, 1 mg/ml of insulin, 0.1 mM of
dexamethasone, 10 mM nicotinamide, 2 mM L-glutamine 50 mM
beta-mercaptoethanol and 1 penicilin/Streptomycin]. The
medium was changed every two to three days until day 18.
From day 18, Hepato-medium(+/ + ) [Hepato-medium(-/-) sup-
plemented with 20 ng/ml of hepatocyte growth factor (HGF,
PHG0324,Life technologies) and 20 ng/ml of epidermal growth
factor (EGF, E9644, Sigma-Aldrich)]. The medium was changed
every two to three days, until days 35 to 40.
2.9. Real-time RT-PCR
Total RNA was harvested and extracted using TRIsol (15596-018,
Thermo Fisher Scientiﬁc) following the manufacturer’s instruction.
The total RNA was extracted from iHep or mock(AxCALRL and
AxCANCre) infected cells in 12 well plate and 1/20 of the sample
were used for reverse transcription using Superscript III reverse
transcriptase (18080044, Thermo Fisher Scientiﬁc). For real-time
PCR, 1/90 of the reverse-transcribed cDNA was used per well, using
Power SYBR Green PCR Master Mix and the following set of
primers:
MaoA; 50-gctgtcaaaatcaagtgcatggtgtattac-30 and 50-
tttccgggcaagtatgaagcccatgat-30,
GstA4; 50-gctatgatttgatactgtcaagagcta-30 and 50-tcttaaatgcctg-
cagcagagggaagt-30,
MaoB; 50-gagagagcagccagagagattctt-30 and 50-gtctctccaggaagg-
tactggtaa-30,
Alpha fetoprotein; 50-attggttacacgaggaaagcacc-30and 50-
agcagtggctgataccagagtt-30,
Albumin; 50-ggcacagtgcttgctgaatttc-30 and 50-ctctgatcttcag-
gaagtgtac-30,
Cadherin; 50-tgctcatgtttcccagcgtgta-30 and 50-aatggcttctctatc-
cagaggc-30, and GPDH;50-ccacttgaagggtggagcca-30 and 50-tcatggat-
gaccttggccag-30.
Each value was standardized by dividing with that of GPDH and
shown as “relative expression level”. The presented data were
means of triplicate experiments.
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iHep and mock(AxCALRL and AxCANCre) infected cells in
12 well plates were washed with PBS() and ﬁxed in with 4%
depolymerized paraformaldehyde in PBS for 15 min. After washing
with water, the cells were oxidized in 0.5% periodic acid solution
(40911, Muto pure chemicals) for 5 min, rinsed in water and placed
in cold Schiff's reagent (40931, Muto pure chemicals) for 15 min.
The cells were washed three times with sulphite solution (0.5%
NaHSO3 supplemented with 0.05N HCl, 40941, Muto pure
chemicals) and once with water. The cells were counterstained
in Mayer's hematoxylin for 2 min and washed in water until the
colour was developed.
2.11. Immunoﬂuorescence
After PAS staining, the cells were washed and blocked with 5%
goat serum (16210-064, Thermo Fisher Scientiﬁc) in PBST (PBS-Fig. 1. A. Schematic representation of the constructed universal adenoviral vector, pAxCA
of genes of interest. All the genes essential for the adenovirus production except E1, are
beta-lactamase gene (ampicillin resistance), the ColE1 origin and Cos sequence, respectiv
the vector can be linearized by digestion with Csp45I or PacI restriction enzymes.
B. Flowchart and timetable for preparation of recombinant adenovirus.
C. Microscope images of HEK293 cells producing AxCALRL-Foxa2 or AxCALRL-Hnf4a rec
pAxCALRL-Hnf4a, and re-plated in 24 well plates. Seven days after transfection, RFP po
particles tends to infect neighbouring cells, the virus producing cells can be observed 
D. and E. Proliferation rates of adenoviruses made to express Hnf4a (D) or Foxa2(E) from
293 cells were infected with the indicated recombinant viruses and the total DNA were e
real-time PCR were normalised to the cellular 28S gene.
F. The ﬁnal titers of adenovirus (the “3rd virus clone” from 10 cm dish).supplemented with 0.1% Tween 20) for 30 min. The cells were
incubated with 1/800 dilution of mouse anti-cadherin (610181, BD
Biosciences) and rabbit anti-albumin (102419, GeneTex) antibodies
in PBST for 1 h. After washing with PBST, the cells were incubated
with goat anti-mouse IgG Alexa Flor555 (A21422, Thermo Fisher
Scientiﬁc) and goat anti-rabbit IgG Alexa Flor 488 (111–545-144,
Jackson ImmunoResearch) for 60 min. Nuclei were stained with a
1/10000 dilution of Hoechst 33342(H3570, Thermo Fisher
Scientiﬁc) in PBS, after incubation with secondary antibody.
Finally, the cells were washed with PBS and photographed with
a ﬂuorescent microscopy (IX71, Olympus).
3. Results
3.1. Construction of a cosmid vector for adenovirus production
The pAxCALRL universal cosmid vector was constructed as
described in the Materials and Methods (see the schematicLRL. The SwaI restriction site located next to 2nd loxP sequence is used for insertion
 located between two ITR (Inverted terminal repeat). Amp, Ori and Cos indicate the
ely. For production of infectious adenovirus particle by transfection of HEK293 cells,
ombinant adenovirus. HEK293 cell cells were transfected with pAxCALRL-Foxa2 or
sitive cells were visualized by ﬂuorescence microscopy. As the budded adenovirus
as RFP positive colonies.
 vectors that contain (CALRL, blue diamonds) or lack (CA, red squares) stuffers. HEK
xtracted at several time points after infection. The amounts of viral DNA detected by
Fig. 2. Efﬁciency of Cre-dependent recombination of AxCALRL viral DNA in infected
MEF.
A. Schematic structure of AxCALRL around the LoxP sites before and after Cre-
dependent recombination. Primer 1(pAxCAF1) and 2(pAxCALRL-r) detect both non-
excised and excised DNA, whereas primers 2 and 3 (RFP 5-f) are speciﬁc for non-
excised DNA.
B. Conﬁrmation of Cre-dependent DNA recombination. MEF infected with AxCALRL-
Foxa2 or AxCALRL-Hnf4, with or without AxCANCre, were cultured and the DNA
was extracted 5 and 7 days after infection. Viral DNA was ampliﬁed by PCR using
primers 1 and 2. The products were separated by agarose electrophoresis. The
250 bp and 1011 bp DNA fragment correspond to excised and non-excised viral DNA,
respectively.
C. Percentage of excised and non-excised viral DNA in infected MEF. The MEF
infected with AxCALRL-Foxa2, AxCALRL-Hnf4a and AxCANCre were cultured for
2 and 5 days and extracted DNA was analysed by real-time PCR using primers 1 and
2 (excised), and 2 and 3 (non-excised). Note that primers 1 and 2 did not detect non-
excised DNA in these experimental condition, as described in the results section.
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recombinant virus within 20–30 days (see the scheme and the time
considerations in Fig. 1B). The cloning methods for cosmid vectors
are similar to plasmids, but certain precautions are necessary.
Cosmid vectors preferentially ligate to short minor DNA fragments.
Long PCR-prepared fragments have to be puriﬁed by techniques
such as agarose gel electrophoresis, to remove even minor
amounts of shorter by products. Glass beads-based methods
should be avoided for the extraction of DNA from gels, since they
can damage DNA, leading to the cloning of deleted fragments.
Colony-PCR methods are preferred to select desired clones, since
the copy number of cosmid vector DNA in E.coli is relatively low, in
comparison with plasmid vectors. Point mutations or deletions of
the insert are sufﬁciently frequent to merit veriﬁcation of the DNA
sequence, in contrast to plasmid cloning. The ligation-packaging
protocol gave 14 and 33 colonies for Foxa2 and Hnf4a, respectively,
and 2 out of 8, and 3 out of 14 clones had the insert in the right
orientation, respectively.
Linearized pAxCALRL-Foxa2 and pAxCALRL-Hnf4a were intro-
duced into HEK293 cells in 6 cm dishes and re-plated on 24 well
plates the next day. RFP positive cells appeared one day after
transfection, and RFP positive colonies, which are a sign of re-
infection by adenovirus, appeared after 6 to 7 days (Fig. 1C). Viral
clones from wells with single colonies were ampliﬁed in
HEK293 cells in 6 cm and then 10 cm plates. Finally, we obtained
10 ml of AxCALRL-Foxa2 and AxCALRL-Hnf4a recombinant adeno-
viruses with titers of 9.1 10^8 pfu/ml and 8.1 10^8 pfu/ml,
respectively. In contrast, the titers of their “non-stuffer” counter-
parts, prepared in the same way, were 6.0  10^8 pfu/ml for AxCA-
Foxa2 and 2.7  10^8 pfu/ml for AxCA-Hnf4a, which were two
thirds and one thirds less than those “with stuffer”, respectively
(Fig. 1F).
3.2. Comparison of the rates of proliferation of adenoviruses with and
without stuffer
In order to compare the effect of stuffer on the efﬁciency of viral
replication, we infected HEK293 cells with AxCALRL-Hnf4a (with
stuffer), AxCA-Hnf4a (without stuffer), AxCALRL-Foxa2 (with
stuffer) and AxCA-Foxa2 (without stuffer) and extracted DNA at
various time points. The amounts of viral and cellular DNA were
analysed by real-time PCR and their ratio was used to estimate the
amount of viral DNA per cells at each time point. AxCALRL-Hnf4a
replicated faster than AxCA-Hnf4a, suggesting that inhibiting
Hnf4a expression with stuffer increased the yield of virus (Fig. 1D).
In contrast, AxCALRL-Foxa2 and AxCA-Foxa2 increased at the same
rate, indicating that the expression of Foxa2 does not affect
proliferation of adenovirus (Fig. 1E).
3.3. Efﬁciency of cre-dependent recombination of AxCALRL DNAin MEF
In order to conﬁrm that Cre recombinase effectively recom-
bined the viral genome, MEF were infected with the adenoviral
vectors AxCALRL-Foxa2 and AxCALRL-Hnf4a. One day later, the
cells were infected with or without the adenoviral vector that
expresses Cre-recombinase. DNA was extracted 2, 5 and 7 days
after the ﬁrst infection, and analysed by PCR using primer 1
(pAxCAF1) and primer 2 (pAxCALRL-r), which were designed to
detect both the excised and the non-excised viral genomes
(Fig. 2A). With Cre recombinase, the 250 bp excised DNA fragment
was detected at days 5 and 7, whereas without Cre the 1011 bp non-
excised fragment was detected in the day 5 sample, indicating that
the majority of viral DNA was excised within 4 day after the
introduction of Cre (Fig. 2B). Non-excised viral DNA was measured
with primers 2 and 3 that are speciﬁc for non-excised DNA
(Fig. 2A). We found by real-time PCR that 55% of viral genome wasexcised at day 2 and 88% at day 5 (Fig. 2C). In these experimental
condition, only the excised DNA was detected with primers 1 plus
2, as shown by electrophoresis of the PCR product, probably due to
the short extension time and the preference for ampliﬁcation of
short DNA fragments.
3.4. Induction of hepatocytes by direct reprogramming
In order to assess whether these Cre-loxP regulated ﬂuorescent
adenoviral expression vectors could be used for direct reprogram-
ming of hepatocytes, MEF were infected with recombinant
adenovirus that express Foxa2 (AxCALRL-Foxa2), Hnf4a
(AxCALRL-Hnf4a) followed by the Cre expression virus, AxCANCre.
After culturing for 20 and 40 days with the indicated protocol
(Fig. 3A), Real-time RT-PCR was used to measure the expression of
mRNAs for hepatocyte differentiation markers [Cadherin, Albumin,
GstA4 (Glutathione S-transferase A4), AFP (Alpha fetoprotein),
MaoA and MaoB (monoamine oxidase A and B)]. The expression of
Fig. 3. Induction of hepatocyte-like cells (induced-Hepatocytes, iHep) from MEF by the expression of Hnf4a and Foxa2 using recombinant adenovirus.
A. Experimental scheme for the induction of hepatocytes. Once a week, cells were infected with AxCALRL-Hnf4a and AxCALRL-Foxa2 followed by AxCANCre on the next day.
The cells were cultured in Hepato-medium(-/-) from day 3 to day 18 and in Hepato-medium(+/ + ) from day 18 to day 40.
B. Expression of hepatocyte marker genes. The total RNA were extracted at day 20 and day 40 and analysed by real-time RT-PCR using speciﬁc primers for Albumin (Alb),
Cadherin (Cdh), GstA4(Glutathione S-transferase A4), AFP (Alpha fetoprotein), MaoA and MaoB (Monoamine oxidases A and B, respectively). The expression levels of mRNA
were normalised by that of GPDH.
C. Microscope images of induced-Hepatocytes. The cells were ﬁxed with formaldehyde 40 days after the 1 st infection and subjected to Periodic acid-Schiff staining followed
by immunostaining using rabbit anti-albumin and mouse anti-cadherin as 1 st antibodies and anti-rabbit and anti-mouse IgG antibodies conjugated with Alexa Fluore
488 and 555, respectively, as 2nd antibodies. Nuclear DNA were stained with Hoechst 33342.
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increased 20 and 40 days after the ﬁrst infection and those for
MaoA and MaoB were augmented to some extent (Fig. 3B). As
hepatocyte cells are rich in glycogen, PAS staining was performed
on cells 40 days after infection. Some colonies stained positively
with PAS. Samples stained with PAS were used for immunoﬂuo-
rescent staining to detect the hepatocyte marker proteins,
Cadherin and Albumin. The PAS-positive cells expressed Cadherin
(green ﬂuorescent cells) and Albumin (red ﬂuorescent cells). These
results show that induced hepatocyte can be generated by the
expression of Foxa2 and Hnf4a using adenoviral vectors.
4. Discussion
Cosmid vectors are not as commonly used as plasmid-based
vectors, but they can be powerful tools for the preparation of
adenovirus vectors. They can hold more than 40 kb of DNA, which
is enough to carry the whole adenovirus genome. The vector needs
to be digested with the restriction enzyme Csp45I before the
introduction into HEK293 cells, in order to produce infectious
virus. Linearisation next to replication origin of adenovirus (the
ITR; inverted terminal repeat) is thought to favour binding of the
precursor terminal protein (pTP) complex, that contains viral DNApolymerase and deoxycytidine needed for DNA replication [5].
Cellular DNA repair mechanisms are thought to generate single
stranded DNA at the site of linearisation, which favours binding of
the complex. The low efﬁciency of this process may limit virus
production. In our experiments, we transfected semi-conﬂuent
HEK293 cells in 6 cm dishes and re-plated them in 24 well plates.
RFP positive colonies appeared in most of the wells, but the
number of the colonies was 1 to 3 per well; therefore only 30 to
100 virus-producing cells were obtained with one transfection. In
our experience, this efﬁcacy is common and is considered to be a
successful preparation of recombinant adenovirus. RFP positive
cells do not always lead to the formation of colonies, probably
because they do not produce infectious virus. AxCALRL contains
stuffer DNA, which prevents expression of potentially toxic
inserted-gene products. AxCALRL-Hnf4a has a doubling time
two hold faster than AxCA-Hnf4a, indicating that Hnf4a expres-
sion inhibits viral replication. In contrast, Foxa2 expression has
little effect on doubling time. The ﬁnal amount of virus obtained
with AxCALRL-Foxa2 (with stuffer) from 10 cm dishes is 1.5 fold
higher than with AxCA-Foxa2, suggesting that high concentrations
of Foxa2 in the cell might inhibit virus production to some extent.
These results indicate that vectors with stuffers can increase the
yield of virus. From our experience, recombinant adenoviruses
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and hinder obtaining sufﬁcient virus for further manipulation. In
this case, we recommend using pAxCALRL or equivalent vector
systems with stuffers.
Control experiments, for the efﬁciency of Cre-loxP dependent
DNA recombination in targeted MEF cells, demonstrated that 50%
of the viral genomes were excised within one day and 90% within
4 days after infection of the recombinant adenovirus that expresses
Cre DNA recombinase (AxCA-NCre). 5 days after the 1 st infection
we could still observe RFP expression by ﬂuorescent microscopy, as
expected from the 10% that was not excised. This residual
expression of RFP can even be helpful, to conﬁrm infection of
targeted cells in some experiments. Otherwise, infecting 10 times
more AxCA-NCre might be necessary to increase DNA recombina-
tion and reduce RFP expression.
Several round of infection were required for reprogramming of
MEF into hepatocytes. Single infections were not sufﬁcient to
induce expression of hepatocyte speciﬁc markers. This could be a
consequence of the loss of non-integrated adenovirus from the
actively dividing cells. We infected once a week, to maintain
expression of the reprogramming factors Hnf4a and Foxa2. With
these conditions, we observed increased expression of hepatocyte
marker genes, including Cadherin, Albumin, GstA4, AFP, MaoA and
MaoB, as well as accumulation of glycogen, a characteristic of
hepatocytes. Cells with accumulated glycogen also expressed
Cadherin and Albumin. In conclusion, we successfully generated
induced-hepatocyte by direct reprogramming with our Cre-loxP
regulated ﬂuorescent adenoviral expression vector system. With
this vector, it is easy to monitor viral replication by ﬂuorescence
and obtain higher titers of virus, in comparison with other systems.
Therefore, this recombinant viral expression system should be
useful for many other applications.
Additional information
The complete sequence of pAxCALRL and its GFP counterpart,
pAxCALGL were presented in Genbank as accession numbers
KX529075 and KX589554, respectively. All the materials with RDB
number can be destributed from RIKEN Bioresource Center DNA
bank (http://dna.brc.riken.jp/index.html). The rest of adenovirus-
related materials will be available by contacting K.N. or dna-
bank@brc.riken.jp.
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